Skip to content

A study to evaluate the effectiveness and safety of chemical peel treatment with homecare products in reducing melasma in 18 male and female adult participants.

An interventional clinical trial to evaluate the efficacy and safety of 3 peel sessions of Activa Peel Forte and Mela Peel Forte combined with Dermaceutic homecare products in adults with skin of color suffering from melasma - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079811
Enrollment
18
Registered
2025-01-30
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Activa Peel Forte: chemical peel product. Onsite Application quantity: as required by the professional applicator Duration: Onsite Visit 2, 3 and 4 Intervention2: Mela Peel Forte: che

Sponsors

Dermaceutic Laboratoire, Dermosciences Espa a
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Participant with Melasma. 2. Participant free of excessive hair, acne, wounds or any other active skin conditions on face. 3. Participant who agrees not to participate in any other clinical research 4. Participant with skin phototype IV to VI according to Fitzpatrick scale 5. Participant willing to refrain from using any other product/ home remedies that could affect the skin, aside from the study products

Exclusion criteria

Exclusion criteria: 1. Participant with dry and sensitive skin. 2. Participant having active skin diseases. 3. Female participant who are pregnant or lactating. 4. Participant who has taken any oral medications or systemic corticosteroids, anti-fungal, antibiotics, hormonal therapy (including oral contraceptives), or any prolonged use of non-steroidal anti-inflammatory, or anti-histaminic within 4 weeks prior to the study. 5. Participant who has undergone any dermatological procedure or facial surgery which might interfere in the study based on investigator s assessment.

Design outcomes

Primary

MeasureTime frame
Efficacy of chemical peel combined with at home skincare regimen in treating melasma through dermatological evaluation, instrumental evaluation and digital imagingTimepoint: Visit 2 Visit 3 Visit 4 Visit 5

Secondary

MeasureTime frame
Evaluation of safety and tolerability of chemical peel by the collection of adverse event and participants questionnaires.Timepoint: Visit 2 Visit 3 Visit 4 Visit 5

Countries

India

Contacts

Public ContactSudhanthiran S

MS Clinical Research Pvt. Ltd

ritambhara@msclinical.com08040917243

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026